A popular blood pressure medication is being recalled due to concerns about potential contamination with another drug.
Glenmark Pharmaceuticals Inc in the US has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, sold under the brand name Ziac. The recall notice issued by the Food and Drug Administration indicates that the tablets might have been tainted with other substances.
These tablets are commonly prescribed to manage high blood pressure, or hypertension, by blocking beta-1 receptors in the heart, as reported by WebMD.
According to the recall notice, testing revealed the presence of ezetimibe, a drug used to address high cholesterol levels. The recall, classified as Class III on December 1, suggests that using or being exposed to the affected product is unlikely to lead to adverse health effects, as stated by the FDA.
The impacted pills are available in 2.5mg and 6.25mg strengths. Specific packages affected include 30-count bottles NDC-68462-878-30, 100-count bottles NDC-68462-878-01, and 500-count bottles NDC-68462-878-05, as outlined in the recall notice.
The affected lot numbers have expiration dates ranging from November 2025 to May 2026, with a total of 11,136 bottles being part of the recall. The FDA has not yet provided guidance on what individuals should do if their medication is included in the recall.